EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

JS Smolen, RBM Landewe, SA Bergstra, A Kerschbaumer, A Sepriano, D Aletaha, R Caporali, CJ Edwards, Kimme Hyrich, JE Pope, S de Souza, TA Stamm, T Takeuchi, P Verschueren, KL Winthrop, A Balsa, JM Bathon, Maya Buch, GR Burmester, F ButtgereitMH Cardiel, K Chatzidionysiou, C Codreanu, M Cutolo, AA den Broeder, K El Aoufy, A Finckh, JE Fonseca, JE Gottenberg, EA Haavardsholm, A Iagnocco, Kim Lauper, ZG Li, IB McInnes, EF Mysler, P Nash, G Poor, GG Ristic, F Rivellese, A Rubbert-Roth, H Schulze-Koops, N Stoilov, A Strangfeld, A van der Helm-van Mil, E van Duuren, TPMV Vlieland, R Westhovens, D van der HeijdeShow 28 moreShow less